Skip to main content
Top
Published in: Respiratory Research 1/2012

Open Access 01-12-2012 | Research

Hypoxia-induced DNA hypermethylation in human pulmonary fibroblasts is associated with Thy-1 promoter methylation and the development of a pro-fibrotic phenotype

Authors: Claire M Robinson, Roisin Neary, Ashleigh Levendale, Chris J Watson, John A Baugh

Published in: Respiratory Research | Issue 1/2012

Login to get access

Abstract

Background

Pulmonary fibrosis is a debilitating and lethal disease with no effective treatment options. Understanding the pathological processes at play will direct the application of novel therapeutic avenues. Hypoxia has been implicated in the pathogenesis of pulmonary fibrosis yet the precise mechanism by which it contributes to disease progression remains to be fully elucidated. It has been shown that chronic hypoxia can alter DNA methylation patterns in tumour-derived cell lines. This epigenetic alteration can induce changes in cellular phenotype with promoter methylation being associated with gene silencing. Of particular relevance to idiopathic pulmonary fibrosis (IPF) is the observation that Thy-1 promoter methylation is associated with a myofibroblast phenotype where loss of Thy-1 occurs alongside increased alpha smooth muscle actin (α-SMA) expression. The initial aim of this study was to determine whether hypoxia regulates DNA methylation in normal human lung fibroblasts (CCD19Lu). As it has been reported that hypoxia suppresses Thy-1 expression during lung development we also studied the effect of hypoxia on Thy-1 promoter methylation and gene expression.

Methods

CCD19Lu were grown for up to 8 days in hypoxia and assessed for global changes in DNA methylation using flow cytometry. Real-time PCR was used to quantify expression of Thy-1, α-SMA, collagen I and III. Genomic DNA was bisulphite treated and methylation specific PCR (MSPCR) was used to examine the methylation status of the Thy-1 promoter.

Results

Significant global hypermethylation was detected in hypoxic fibroblasts relative to normoxic controls and was accompanied by increased expression of myofibroblast markers. Thy-1 mRNA expression was suppressed in hypoxic cells, which was restored with the demethylating agent 5-aza-2-deoxycytidine. MSPCR revealed that Thy-1 became methylated following fibroblast exposure to 1% O2.

Conclusion

These data suggest that global and gene-specific changes in DNA methylation may play an important role in fibroblast function in hypoxia.
Appendix
Available only for authorised users
Literature
2.
go back to reference Navaratnam V, Fleming KM, West J, Smith CJ, Jenkins RG, Fogarty A, Hubbard RB: The rising incidence of idiopathic pulmonary fibrosis in the U.K. Thorax. 2011, 66 (6): 462-467. 10.1136/thx.2010.148031.PubMedCrossRef Navaratnam V, Fleming KM, West J, Smith CJ, Jenkins RG, Fogarty A, Hubbard RB: The rising incidence of idiopathic pulmonary fibrosis in the U.K. Thorax. 2011, 66 (6): 462-467. 10.1136/thx.2010.148031.PubMedCrossRef
3.
go back to reference Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, et al: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011, 183 (6): 788-824. 10.1164/rccm.2009-040GL.PubMedCrossRef Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, et al: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011, 183 (6): 788-824. 10.1164/rccm.2009-040GL.PubMedCrossRef
4.
go back to reference Ley B, Collard HR, King TE: Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011, 183 (4): 431-440. 10.1164/rccm.201006-0894CI.PubMedCrossRef Ley B, Collard HR, King TE: Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011, 183 (4): 431-440. 10.1164/rccm.201006-0894CI.PubMedCrossRef
6.
go back to reference Tzouvelekis A, Harokopos V, Paparountas T, Oikonomou N, Chatziioannou A, Vilaras G, Tsiambas E, Karameris A, Bouros D, Aidinis V: Comparative Expression Profiling in Pulmonary Fibrosis suggests a Role of Hypoxia Inducible Factor-1α in disease pathogenesis. Am J Respir Crit Care Med. 2007, 176: 1108-1119. 10.1164/rccm.200705-683OC.PubMedCrossRef Tzouvelekis A, Harokopos V, Paparountas T, Oikonomou N, Chatziioannou A, Vilaras G, Tsiambas E, Karameris A, Bouros D, Aidinis V: Comparative Expression Profiling in Pulmonary Fibrosis suggests a Role of Hypoxia Inducible Factor-1α in disease pathogenesis. Am J Respir Crit Care Med. 2007, 176: 1108-1119. 10.1164/rccm.200705-683OC.PubMedCrossRef
7.
go back to reference Shahrzad S, Bertrand K, Minhas K, Coomber BL: Induction of DNA hypomethylation by tumor hypoxia. Epigenetics. 2007, 2 (2): 119-125. 10.4161/epi.2.2.4613.PubMedCrossRef Shahrzad S, Bertrand K, Minhas K, Coomber BL: Induction of DNA hypomethylation by tumor hypoxia. Epigenetics. 2007, 2 (2): 119-125. 10.4161/epi.2.2.4613.PubMedCrossRef
8.
go back to reference Skowronski K, Dubey S, Rodenhiser D, Coomber B: Ischemia dysregulates DNA methyltransferases and p16INK4a methylation in human colorectal cancer cells. Epigenetics. 2010, 5 (6): 547-556. 10.4161/epi.5.6.12400.PubMedPubMedCentralCrossRef Skowronski K, Dubey S, Rodenhiser D, Coomber B: Ischemia dysregulates DNA methyltransferases and p16INK4a methylation in human colorectal cancer cells. Epigenetics. 2010, 5 (6): 547-556. 10.4161/epi.5.6.12400.PubMedPubMedCentralCrossRef
9.
go back to reference Watson JA, Watson CJ, McCrohan AM, Woodfine K, Tosetto M, McDaid J, Gallagher E, Betts D, Baugh J, O'Sullivan J, Murrell A, Watson RW, McCann A: Generation of an epigenetic signature by chronic hypoxia in prostate cells. Hum Mol Genet. 2009, 18 (19): 3594-3604. 10.1093/hmg/ddp307.PubMedCrossRef Watson JA, Watson CJ, McCrohan AM, Woodfine K, Tosetto M, McDaid J, Gallagher E, Betts D, Baugh J, O'Sullivan J, Murrell A, Watson RW, McCann A: Generation of an epigenetic signature by chronic hypoxia in prostate cells. Hum Mol Genet. 2009, 18 (19): 3594-3604. 10.1093/hmg/ddp307.PubMedCrossRef
10.
go back to reference Egger G, Liang G, Aparicio A, Jones PA: Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004, 429 (6990): 457-463. 10.1038/nature02625.PubMedCrossRef Egger G, Liang G, Aparicio A, Jones PA: Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004, 429 (6990): 457-463. 10.1038/nature02625.PubMedCrossRef
11.
go back to reference Sanders YY, Ambalavanan N, Halloran B, Zhang X, Liu H, Crossman DK, Bray M, Zhang K, Thannickal VJ, Hagood JS: Altered Dna Methylation Profile In Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2012, Epub ahead of print Sanders YY, Ambalavanan N, Halloran B, Zhang X, Liu H, Crossman DK, Bray M, Zhang K, Thannickal VJ, Hagood JS: Altered Dna Methylation Profile In Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2012, Epub ahead of print
12.
go back to reference Rabinovich EI, Kapetanaki MG, Steinfeld I, Gibson KF, Pandit KV, Yu G, Yakhini Z, Kaminski N: Global methylation patterns in idiopathic pulmonary fibrosis. PLoS One. 2012, 7 (4): e33770-10.1371/journal.pone.0033770.PubMedPubMedCentralCrossRef Rabinovich EI, Kapetanaki MG, Steinfeld I, Gibson KF, Pandit KV, Yu G, Yakhini Z, Kaminski N: Global methylation patterns in idiopathic pulmonary fibrosis. PLoS One. 2012, 7 (4): e33770-10.1371/journal.pone.0033770.PubMedPubMedCentralCrossRef
13.
go back to reference Huang SK, Fisher AS, Scruggs AM, White ES, Hogaboam CM, Richardson BC, Peters-Golden M: Hypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice. Am J Pathol. 2010, 177 (5): 2245-2255. 10.2353/ajpath.2010.100446.PubMedPubMedCentralCrossRef Huang SK, Fisher AS, Scruggs AM, White ES, Hogaboam CM, Richardson BC, Peters-Golden M: Hypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice. Am J Pathol. 2010, 177 (5): 2245-2255. 10.2353/ajpath.2010.100446.PubMedPubMedCentralCrossRef
14.
go back to reference Robinson CM, Watson CJ, Baugh JA: Epigenetics within the Matrix: a neo-regulator of fibrotic disease. Epigenetics. 2012, 7: 9-[Epub ahead of printCrossRef Robinson CM, Watson CJ, Baugh JA: Epigenetics within the Matrix: a neo-regulator of fibrotic disease. Epigenetics. 2012, 7: 9-[Epub ahead of printCrossRef
15.
go back to reference Sanders YY, Pardo A, Selman M, Nuovo GJ, Tollefsbol TO, Siegal GP, Hagood JS: Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2008, 39 (5): 610-618. 10.1165/rcmb.2007-0322OC.PubMedPubMedCentralCrossRef Sanders YY, Pardo A, Selman M, Nuovo GJ, Tollefsbol TO, Siegal GP, Hagood JS: Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2008, 39 (5): 610-618. 10.1165/rcmb.2007-0322OC.PubMedPubMedCentralCrossRef
16.
go back to reference Cisneros J, Hagood J, Checa M, Ortiz-Quintero B, Negreros M, Herrera I, Ramos C, Pardo A, Selman M: Hypermethylation-mediated silencing of p14ARF in fibroblasts from idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2012, 303 (4): L295-L303. 10.1152/ajplung.00332.2011.PubMedCrossRef Cisneros J, Hagood J, Checa M, Ortiz-Quintero B, Negreros M, Herrera I, Ramos C, Pardo A, Selman M: Hypermethylation-mediated silencing of p14ARF in fibroblasts from idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2012, 303 (4): L295-L303. 10.1152/ajplung.00332.2011.PubMedCrossRef
17.
go back to reference Zhou Y, Hagood JS, Lu B, Merryman WD, Murphy-Ullrich JE: Thy-1-integrin alphav beta5 interactions inhibit lung fibroblast contraction-induced latent transforming growth factor-beta1 activation and myofibroblast differentiation. J Biol Chem. 2010, 285 (29): 22382-22293. 10.1074/jbc.M110.126227.PubMedPubMedCentralCrossRef Zhou Y, Hagood JS, Lu B, Merryman WD, Murphy-Ullrich JE: Thy-1-integrin alphav beta5 interactions inhibit lung fibroblast contraction-induced latent transforming growth factor-beta1 activation and myofibroblast differentiation. J Biol Chem. 2010, 285 (29): 22382-22293. 10.1074/jbc.M110.126227.PubMedPubMedCentralCrossRef
18.
go back to reference Rege TA, Hagood JS: Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses. Biochim Biophys Acta. 2006, 1763 (10): 991-999. 10.1016/j.bbamcr.2006.08.008.PubMedPubMedCentralCrossRef Rege TA, Hagood JS: Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses. Biochim Biophys Acta. 2006, 1763 (10): 991-999. 10.1016/j.bbamcr.2006.08.008.PubMedPubMedCentralCrossRef
19.
go back to reference Bradley JE, Ramirez G, Hagood JS: Roles and regulation of Thy-1, a context dependent modulator of cell phenotype. Biofactors. 2009, 35 (3): 258-265. 10.1002/biof.41.PubMedCrossRef Bradley JE, Ramirez G, Hagood JS: Roles and regulation of Thy-1, a context dependent modulator of cell phenotype. Biofactors. 2009, 35 (3): 258-265. 10.1002/biof.41.PubMedCrossRef
20.
go back to reference Hagood JS, Prabhakaran P, Kumbla P, Salazar L, MacEwen MW, Barker TH, Ortiz LA, Schoeb T, Siegal GP, Alexander CB, Pardo A, Selman M: Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis. Am J Pathol. 2005, 167 (2): 365-379. 10.1016/S0002-9440(10)62982-3.PubMedPubMedCentralCrossRef Hagood JS, Prabhakaran P, Kumbla P, Salazar L, MacEwen MW, Barker TH, Ortiz LA, Schoeb T, Siegal GP, Alexander CB, Pardo A, Selman M: Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis. Am J Pathol. 2005, 167 (2): 365-379. 10.1016/S0002-9440(10)62982-3.PubMedPubMedCentralCrossRef
21.
go back to reference Ramirez G, Hagood JS, Sanders Y, Ramirez R, Becerril C, Segura L, Barrera L, Selman M, Pardo A: Absence of Thy-1 results in TGF-beta induced MMP-9 expression and confers a profibrotic phenotype to human lung fibroblasts. Lab Invest. 2011, 91 (8): 1206-1218. 10.1038/labinvest.2011.80.PubMedCrossRef Ramirez G, Hagood JS, Sanders Y, Ramirez R, Becerril C, Segura L, Barrera L, Selman M, Pardo A: Absence of Thy-1 results in TGF-beta induced MMP-9 expression and confers a profibrotic phenotype to human lung fibroblasts. Lab Invest. 2011, 91 (8): 1206-1218. 10.1038/labinvest.2011.80.PubMedCrossRef
22.
go back to reference Sanders YY, Kumbla P, Hagood JS: Enhanced myofibroblastic differentiation and survival in Thy-1(-) lung fibroblasts. Am J Respir Cell Mol Biol. 2007, 36 (2): 226-235.PubMedPubMedCentralCrossRef Sanders YY, Kumbla P, Hagood JS: Enhanced myofibroblastic differentiation and survival in Thy-1(-) lung fibroblasts. Am J Respir Cell Mol Biol. 2007, 36 (2): 226-235.PubMedPubMedCentralCrossRef
23.
go back to reference Sanders YY, Tollefsbol TO, Varisco BM, Hagood JS: Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts. Am J Respir Cell Mol Biol. 2011, 45 (1): 16-23. 10.1165/rcmb.2010-0154OC.PubMedPubMedCentralCrossRef Sanders YY, Tollefsbol TO, Varisco BM, Hagood JS: Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts. Am J Respir Cell Mol Biol. 2011, 45 (1): 16-23. 10.1165/rcmb.2010-0154OC.PubMedPubMedCentralCrossRef
24.
go back to reference Nicola T, Hagood JS, James ML, Macewen MW, Williams TA, Hewitt MM, Schwiebert L, Bulger A, Oparil S, Chen YF, Ambalavanan N: Loss of Thy-1 inhibits alveolar development in the newborn mouse lung. Am J Physiol Lung Cell Mol Physiol. 2009, 296 (5): L738-L750. 10.1152/ajplung.90603.2008.PubMedPubMedCentralCrossRef Nicola T, Hagood JS, James ML, Macewen MW, Williams TA, Hewitt MM, Schwiebert L, Bulger A, Oparil S, Chen YF, Ambalavanan N: Loss of Thy-1 inhibits alveolar development in the newborn mouse lung. Am J Physiol Lung Cell Mol Physiol. 2009, 296 (5): L738-L750. 10.1152/ajplung.90603.2008.PubMedPubMedCentralCrossRef
25.
go back to reference Falanga V, Qian SW, Danielpour D, Katz MH, Roberts AB, Sporn MB: Hypoxia upregulates the synthesis of TGF-beta 1 by human dermal fibroblasts. J Invest Dermatol. 1991, 97 (4): 634-637. 10.1111/1523-1747.ep12483126.PubMedCrossRef Falanga V, Qian SW, Danielpour D, Katz MH, Roberts AB, Sporn MB: Hypoxia upregulates the synthesis of TGF-beta 1 by human dermal fibroblasts. J Invest Dermatol. 1991, 97 (4): 634-637. 10.1111/1523-1747.ep12483126.PubMedCrossRef
26.
go back to reference Short M, Nemenoff RA, Zawada WM, Stenmark KR, Das M: Hypoxia induces differentiation of pulmonary artery adventitial fibroblasts into myofibroblasts. Am J Physiol Cell Physiol. 2004, 286 (2): C416-C425. 10.1152/ajpcell.00169.2003.PubMedCrossRef Short M, Nemenoff RA, Zawada WM, Stenmark KR, Das M: Hypoxia induces differentiation of pulmonary artery adventitial fibroblasts into myofibroblasts. Am J Physiol Cell Physiol. 2004, 286 (2): C416-C425. 10.1152/ajpcell.00169.2003.PubMedCrossRef
27.
go back to reference Misra S, Fu AA, Misra KD, Shergill UM, Leof EB, Mukhopadhyay D: Hypoxia-induced phenotypic switch of fibroblasts to myofibroblasts through a matrix metalloproteinase 2/tissue inhibitor of metalloproteinase-mediated pathway: implications for venous neointimal hyperplasia in hemodialysis access. J Vasc Interv Radiol. 2010, 21 (6): 896-902. 10.1016/j.jvir.2010.02.030.PubMedPubMedCentralCrossRef Misra S, Fu AA, Misra KD, Shergill UM, Leof EB, Mukhopadhyay D: Hypoxia-induced phenotypic switch of fibroblasts to myofibroblasts through a matrix metalloproteinase 2/tissue inhibitor of metalloproteinase-mediated pathway: implications for venous neointimal hyperplasia in hemodialysis access. J Vasc Interv Radiol. 2010, 21 (6): 896-902. 10.1016/j.jvir.2010.02.030.PubMedPubMedCentralCrossRef
28.
go back to reference Norman JT, Clark IM, Garcia PL: Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int. 2000, 58 (6): 2351-2366. 10.1046/j.1523-1755.2000.00419.x.PubMedCrossRef Norman JT, Clark IM, Garcia PL: Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int. 2000, 58 (6): 2351-2366. 10.1046/j.1523-1755.2000.00419.x.PubMedCrossRef
29.
go back to reference Watson JA, Watson CJ, McCann A, Baugh J: Epigenetics, the epicenter of the hypoxic response. Epigenetics. 2010, 5 (4): 293-296. 10.4161/epi.5.4.11684.PubMedCrossRef Watson JA, Watson CJ, McCann A, Baugh J: Epigenetics, the epicenter of the hypoxic response. Epigenetics. 2010, 5 (4): 293-296. 10.4161/epi.5.4.11684.PubMedCrossRef
30.
go back to reference Bechtel W, McGoohan S, Zeisberg EM, Muller GA, Kalbacher H, Salant DJ, Muller CA, Kalluri R, Zeisberg M: Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med. 2010, 16 (5): 544-550. 10.1038/nm.2135.PubMedPubMedCentralCrossRef Bechtel W, McGoohan S, Zeisberg EM, Muller GA, Kalbacher H, Salant DJ, Muller CA, Kalluri R, Zeisberg M: Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med. 2010, 16 (5): 544-550. 10.1038/nm.2135.PubMedPubMedCentralCrossRef
32.
go back to reference Tao H, Huang C, Yang JJ, Ma TT, Bian EB, Zhang L, Lv XW, Jin Y, Li J: MeCP2 controls the expression of RASAL1 in the hepatic fibrosis in rats. Toxicology. 2011, 290 (2-3): 328-334.CrossRef Tao H, Huang C, Yang JJ, Ma TT, Bian EB, Zhang L, Lv XW, Jin Y, Li J: MeCP2 controls the expression of RASAL1 in the hepatic fibrosis in rats. Toxicology. 2011, 290 (2-3): 328-334.CrossRef
33.
go back to reference Hu B, Gharaee-Kermani M, Wu Z, Phan SH: Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis. Am J Pathol. 2011, 178 (4): 1500-1508. 10.1016/j.ajpath.2011.01.002.PubMedPubMedCentralCrossRef Hu B, Gharaee-Kermani M, Wu Z, Phan SH: Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis. Am J Pathol. 2011, 178 (4): 1500-1508. 10.1016/j.ajpath.2011.01.002.PubMedPubMedCentralCrossRef
34.
go back to reference Mann J, Oakley F, Akiboye F, Elsharkawy A, Thorne AW, Mann DA: Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis. Cell Death Differ. 2007, 14 (2): 275-285. 10.1038/sj.cdd.4401979.PubMedCrossRef Mann J, Oakley F, Akiboye F, Elsharkawy A, Thorne AW, Mann DA: Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis. Cell Death Differ. 2007, 14 (2): 275-285. 10.1038/sj.cdd.4401979.PubMedCrossRef
35.
go back to reference Mann J, Chu DC, Maxwell A, Oakley F, Zhu NL, Tsukamoto H, Mann DA: MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology. 2010, 138 (2): 705-14-714 e1-4.CrossRef Mann J, Chu DC, Maxwell A, Oakley F, Zhu NL, Tsukamoto H, Mann DA: MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology. 2010, 138 (2): 705-14-714 e1-4.CrossRef
36.
go back to reference Davies ER, Haitchi HM, Thatcher TH, Sime PJ, Kottmann RM, Ganesan A, Packham G, O'Reilly KM, Davies DE: Spiruchostatin a inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis. Am J Respir Cell Mol Biol. 2012, 46 (5): 687-694. 10.1165/rcmb.2011-0040OC.PubMedCrossRef Davies ER, Haitchi HM, Thatcher TH, Sime PJ, Kottmann RM, Ganesan A, Packham G, O'Reilly KM, Davies DE: Spiruchostatin a inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis. Am J Respir Cell Mol Biol. 2012, 46 (5): 687-694. 10.1165/rcmb.2011-0040OC.PubMedCrossRef
37.
go back to reference Melvin A, Rocha S: Chromatin as an oxygen sensor and active player in the hypoxia response. Cell Signal. 2012, 24 (1): 35-43. 10.1016/j.cellsig.2011.08.019.PubMedPubMedCentralCrossRef Melvin A, Rocha S: Chromatin as an oxygen sensor and active player in the hypoxia response. Cell Signal. 2012, 24 (1): 35-43. 10.1016/j.cellsig.2011.08.019.PubMedPubMedCentralCrossRef
38.
go back to reference Zhou Y, Hagood JS, Murphy-Ullrich JE: Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli. Am J Pathol. 2004, 165 (2): 659-669. 10.1016/S0002-9440(10)63330-5.PubMedPubMedCentralCrossRef Zhou Y, Hagood JS, Murphy-Ullrich JE: Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli. Am J Pathol. 2004, 165 (2): 659-669. 10.1016/S0002-9440(10)63330-5.PubMedPubMedCentralCrossRef
Metadata
Title
Hypoxia-induced DNA hypermethylation in human pulmonary fibroblasts is associated with Thy-1 promoter methylation and the development of a pro-fibrotic phenotype
Authors
Claire M Robinson
Roisin Neary
Ashleigh Levendale
Chris J Watson
John A Baugh
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2012
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-13-74

Other articles of this Issue 1/2012

Respiratory Research 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.